Skip to main content
. 2021 Aug 18;11:16787. doi: 10.1038/s41598-021-96340-5

Figure 2.

Figure 2

Clinical characteristics of the breast cancer patients used in this study. (A) Availability of clinical data in the included cohorts; (B) the proportion of patients treated with radiation, hormones or chemotherapy. (C) Percentage of patients by nodal status in each dataset; (D), (E) the proportion of patients by receptor status for ESR1, PGR and HER2 in each dataset; (F) the distribution of stage and grade; (G) the mean age of patients; and (H) the mean follow-up time in each dataset.